Clinical Trials in Detroit

Showing 10761-10780 of 19,719 trials

Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.

NCT03680898

The primary purpose of this clinical investigation is to establish the performance of the GenePOC Carba assay on the revogene. This will be achieved by comparing the test to a conventional method for detection of Carbapenemase Producing Organisms (CPOs) in rectal swab samples.

Carbapenem-Resistant Enterobacteriaceae

Meridian Bioscience, Inc.1,200 participantsStarted Feb 2019

Indianapolis, Indiana, United States • Detroit, Michigan, United States • Toronto, Ontario, Canada

UNKNOWNPhase 3< 1 mile

Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

NCT03250338

This is a randomized, multi-center, double-blind, placebo-controlled study designed to evaluate the efficacy of crenolanib administered following salvage chemotherapy, consolidation chemotherapy, post bone marrow transplantation and as maintenance in relapsed/refractory AML subjects with FLT3 activating mutation.

Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations

Arog Pharmaceuticals, Inc.322 participantsStarted Jun 2018

Sacramento, California, United States • Sacramento, California, United States • Gainesville, Florida, United States +59 more locations

Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.

Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

Find Trials by Condition in Detroit

Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

Pain After Insufflation for Robotic Sacrocolpopexy (PAIRS) Trial

SOFI: A Quality Improvement Project to Standardize Use of Intravenous Fluids in Hospitalized Pediatric Patients

Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)

Age of Blood in Children in Pediatric Intensive Care Units

GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer

Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries

Global Anticoagulant Registry in the Field

Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer

Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus

Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

Comparison of the ToFscan and TetraGraph During Recovery of Neuromuscular Function in the Post Anesthesia Care Unit

Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome

Trial of High-dose Urso in Primary Sclerosing Cholangitis

Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease

Managing Childhood Abdominal Pain